Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Muscle Contraction Process (N/A)
- Target
- N/A
- Molecular classification
- Biological Process, Cellular Process
01
Overview
The muscle contraction process is the physiological mechanism by which muscle fibers generate force and shorten, enabling movement and stability in the body. This involves a complex interplay of molecular components, including actin, myosin, troponin, tropomyosin, calcium ions, and ATP. The process is initiated by a nerve impulse, leading to calcium release and subsequent crossbridge cycling between actin and myosin filaments. Regulation occurs via neural input, calcium concentration, and ATP availability. Dysfunction in any component can lead to various muscular diseases and dysfunctions.
- Other names
- Muscle contractionSkeletal muscle contractionCardiac muscle contractionSmooth muscle contractionSliding Filament TheoryExcitation-Contraction Coupling
02
Mechanism of action
Drugs can affect muscle contraction by various mechanisms, including: - Blocking neuromuscular transmission - Inhibiting calcium release from the sarcoplasmic reticulum - Interfering with actin-myosin interaction - Affecting calcium reuptake into the sarcoplasmic reticulum - Modulating neuronal signaling pathways involved in muscle control
03
Biological functions
Muscle movementForce generationBody stabilizationHeat generationLocomotionPostureCardiac functionPeristalsis
04
Disease associations
Muscular dystrophyMyasthenia gravisHeart failureSpasticityMuscle crampsRhabdomyolysisMalignant hyperthermia
05
Safety considerations
Muscle weaknessRespiratory depressionCardiac arrhythmiasMalignant hyperthermiaDrug interactionsRhabdomyolysis
06
Interacting drugs
Neuromuscular blocking agents (e.g., rocuronium, succinylcholine)
3 more in the full profile.
07
Biomarkers
Creatine kinase (CK)Troponin (cardiac muscle damage)Lactate dehydrogenase (LDH)Calcium levelsAntibodies against acetylcholine receptors (Myasthenia gravis)Genetic markers for specific muscular dystrophies
Beyond the preview
Go deeper on Muscle Contraction Process (N/A).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Muscle Contraction Process (N/A).